Recent Company News

• 08:51 AM ET Jun 13, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 04:44 AM ET Jun 13, 2025
  

  CSPC Pharmaceutical to collaborate with AstraZeneca on developing novel oral small molecule candidates using CSPC's AI-driven platform (HK$8.84, 0.00)

• 04:02 AM ET Jun 10, 2025
  

  StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (38 total)

• 12:18 AM ET Jun 10, 2025
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (115 total)

• 03:52 AM ET Jun 06, 2025
  

  StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (28 total)

• 06:22 PM ET Jun 05, 2025
  

  CSPC Pharmaceutical Group upgraded to buy from hold at HSBC (HK$7.86, 0.00)

• 12:19 AM ET Jun 05, 2025
  

  StreetAccount Sector Summary - China Healthcare May Recap

• 11:02 PM ET Jun 03, 2025
  

  StreetAccount Summary - Trading higher/lower: Hong Kong mid-morning

• 06:47 AM ET Jun 02, 2025
  

  NMPA grants Breakthrough Therapy Designation for CSPC Pharmaceutical's JMT101 to be combined with irinotecan for colorectal cancer (HK$7.71, 0.00)

• 08:47 PM ET Jun 01, 2025
  

  CSPC Pharmaceutical Group downgraded to underperform from hold at Jefferies (HK$8.10, 0.00)